Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor–Associated Reduction in Heart Failure Hospitalizations

Authors: LITTLETON, SHANA D.R. ¹, LANFEAR, DAVID E. ², DORSCH, MICHAEL P. ¹, LIU, BIN ², LUZUM, JASMINE A. ^{1, ⁎}

Source: In Journal of Cardiac Failure May 2025 31(5):800-809

HLA variation associated with peanut allergy and anaphylaxis among non-Hispanic Black individuals

Authors: Wu, Baojun ^{a, ∗}, Yang, Mao ^a, Hu, Donglei ^b, Zhang, Ray ^a, Liu, Bin ^a, Hochstadt, Samantha ^a, Lanfear, David E. ^a, Witonsky, Jonathan ^c, Kumar, Rajesh ^{d, e}, Hollenbach, Jill A. ^{f, g}, Burchard, Esteban G. ^b, Ziv, Elad ^b, Williams, L. Keoki ^{a, ∗}

Source: In Journal of Allergy and Clinical Immunology: Global March 2025

The iATTEND Trial: A Trial Comparing Hybrid Versus Standard Cardiac Rehabilitation

Authors: Keteyian, Steven J., Grimshaw, Crystal, Ehrman, Jonathan K., Kerrigan, Dennis J., Abdul-Nour, Khaled, Lanfear, David E., Brawner, Clinton A.

Source: In The American Journal of Cardiology 15 June 2024 221:94-101

Dysregulation of cardiac mitochondrial aldehyde dehydrogenase 2: Studies in dogs with chronic heart failure

Authors: Gupta, Ramesh C., Singh-Gupta, Vinita, Szekely, Kristina J., Zhang, Kefei, Lanfear, David E., Sabbah, Hani N.

Source: In Journal of Molecular and Cellular Cardiology Plus June 2024 8

Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

Authors: Felker, G. Michael ^{1, ⁎}, Solomon, Scott D. ², Metra, Marco ³, Mcmurray, John J.V. ⁴, Diaz, Rafael ⁵, Claggett, Brian ², Lanfear, David E. ⁶, Vandekerckhove, Hans ⁷, Biering-Sørensen, Tor ⁸, Lopes, Renato D. ¹, Arias-Mendoza, Alexandra ⁹, Momomura, Shin-Ichi ¹⁰, Corbalan, Ramon ¹¹, Ramires, Felix J.A. ¹², Zannad, Faiez ¹³, Heitner, Stephen B. ¹⁴, Divanji, Punag H. ¹⁴, Kupfer, Stuart ¹⁴, Malik, Fady I. ¹⁴, Teerlink, John R. ¹⁵

Source: In Journal of Cardiac Failure June 2024 30(6):755-763

Recruitment Strategies of a Decentralized Randomized Placebo Controlled Clinical Trial: The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Trial

Authors: Nassif, MICHAEL, BIRMINGHAM, MARY C., LANFEAR, DAVID E., GOLBUS, JESSICA R., GUPTA, BHANU, FAWCETT, CHRISTINA, HARRISON, MARIA C., SPERTUS, JOHN A.

Source: In Journal of Cardiac Failure June 2023 29(6):863-869

Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF

Authors: Lanfear, David E., Njoroge, Joyce N., Adams, Kirkwood F., Anand, Inder, Fang, James C., Ramires, Felix, Sliwa-Hahnle, Karen, Badat, Aysha, Burgess, Lesley, Gorodeski, Eiran Z., Williams, Celeste, Diaz, Rafael, Felker, Gary M., McMurray, John J.V., Metra, Marco, Solomon, Scott, Miao, Zi Michael, Claggett, Brian L., Heitner, Stephen B., Kupfer, Stuart, Malik, Fady I., Teerlink, John R.

Source: In JACC: Heart Failure May 2023 11(5):569-579

Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device

Authors: Mehra, Mandeep R., Nayak, Aditi, Morris, Alanna A., Lanfear, David E., Nemeh, Hassan, Desai, Sapna, Bansal, Aditya, Guerrero-Miranda, Cesar, Hall, Shelley, Cleveland, Joseph C., Jr., Goldstein, Daniel J., Uriel, Nir, Chen, Leway, Bailey, Stephen, Anyanwu, Anelechi, Heatley, Gerald, Chuang, Joyce, Estep, Jerry D.

Source: In JACC: Heart Failure December 2022 10(12):948-959

The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF

Authors: RAO, VISHAL N., KALTENBACH, LISA A., GRANGER, BRADI B., FONAROW, GREGG C., AL-KHALIDI, HUSSEIN R., ALBERT, NANCY M., BUTLER, JAVED, ALLEN, LARRY A., LANFEAR, DAVID E., ARIELY, DAN, MILLER, JULIE M., BRODSKY, MICHAEL A., LALONDE, THOMAS A., LAFFERTY, JAMES C., GRANGER, CHRISTOPHER B., HERNANDEZ, ADRIAN F., DEVORE, ADAM D.

Source: In Journal of Cardiac Failure October 2022 28(10):1487-1496

Evidence of Hyperacetylation of Mitochondrial Regulatory Proteins in Left Ventricular Myocardium of Dogs with Chronic Heart Failure.

Authors: Gupta, Ramesh C., Szekely, Kristina, Zhang, Kefei, Lanfear, David E., Sabbah, Hani N.

Source: International Journal of Molecular Sciences; Apr2025, Vol. 26 Issue 8, p3856, 10p

Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry

Authors: LALA, ANURADHA ^*, SHAH, PALAK ^*, KHALATBARI, SHOKOUFEH, YOSEF, MATHEOS, MOUNTIS, MARIA M., ROBINSON, SHAWN W., LANFEAR, DAVID E., ESTEP, JERRY D., JEFFRIES, NEAL, TADDEI-PETERS, WENDY C., STEVENSON, LYNNE W., RICHARDS, BLAIR, MANN, DOUGLAS L., MANCINI, DONNA M., STEWART, GARRICK C., AARONSON, KEITH D.

Source: In Journal of Cardiac Failure May 2022 28(5):765-774

Label Space Transfer Learning

Authors: Al-Stouhi, Samir, Reddy, Chandan K., Lanfear, David E.

Source: 2012 IEEE 24th International Conference on Tools with Artificial Intelligence Tools with Artificial Intelligence (ICTAI), 2012 IEEE 24th International Conference on. 1:727-734 Nov, 2012

Relation: 2012 IEEE 24th International Conference on Tools with Artificial Intelligence (ICTAI)

Survival Association of Angiotensin Inhibitors in Heart Failure With Reduced Ejection Fraction: Comparisons Using Self-Identified Race and Genomic Ancestry

Authors: Luzum, JASMINE A., EDOKOBI, OZIOMA, DORSCH, MICHAEL P., PETERSON, EDWARD, LIU, BIN, GUI, HONGSHENG, WILLIAMS, L. KEOKI, LANFEAR, DAVID E.

Source: In Journal of Cardiac Failure February 2022 28(2):215-225

Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure

Authors: Lala, Anuradha, Shah, Keyur B., Lanfear, David E., Thibodeau, Jennifer T., Palardy, Maryse, Ambardekar, Amrut V., McNamara, Dennis M., Taddei-Peters, Wendy C., Baldwin, J. Timothy, Jeffries, Neal, Khalatbari, Shokoufeh, Spino, Cathie, Richards, Blair, Mann, Douglas L., Stewart, Garrick C., Aaronson, Keith D., Mancini, Donna M.

Source: In JACC: Heart Failure March 2021 9(3):226-236

Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF.

Authors: Satoshi Shoji, Kaltenbach, Lisa, Granger, Bradi B., Fonarow, Gregg C., Al-Khalidi, Hussein R., Albert, Nancy M., Butler, Javed, Allen, Larry A., Lanfear, David E., Thibodeau, Jennifer T., Chapman, Brittany M., Oliver-McNeil, Sandra M., Felker, G. Michael, Pina, Ileana L., Granger, Christopher B., Hernandez, Adrian F., DeVore, Adam D.

Source: Journal of the American Heart Association; 12/17/2024, Vol. 13 Issue 24, p1-12, 12p

Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

Authors: Loungani, Rahul S., Teerlink, John R., Metra, Marco, Allen, Larry A., Butler, Javed, Carson, Peter E., Chen, Chien-Wei, Cotter, Gad, Davison, Beth A., Eapen, Zubin J., Filippatos, Gerasimos S., Gimpelewicz, Claudio, Greenberg, Barry, Holbro, Thomas, Januzzi, James L., Jr., Lanfear, David E., Pang, Peter S., Piña, Ileana L., Ponikowski, Piotr, Miller, Alan B., Voors, Adriaan A., Felker, G. Michael

Source: In JACC: Heart Failure December 2020 8(12):999-1008

Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction

Authors: Aurora, Lindsey, Peterson, Edward, Gui, Hongsheng, Zeld, Nicole, McCord, James, Pinto, Yigal, Cook, Bernard, Sabbah, Hani N., Keoki Williams, L., Snider, James, Lanfear, David E.

Source: In Clinica Chimica Acta November 2020 510:767-771

Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence

Authors: Tchoukina, Inna, Shah, Keyur B., Thibodeau, Jennifer T., Estep, Jerry D., Lala, Anuradha, Lanfear, David E., Gilotra, Nisha A., Pamboukian, Salpy V., Horstmanshof, Douglas A., Mcnamara, Dennis M., Haas, Donald C., Jorde, Ulrich P., Mclean, Rhondalyn C., Cascino, Thomas M., Khalatbari, Shokoufeh, Richards, Blair, Yosef, Matheos, Spino, Cathie, Baldwin, J. Timothy, Mann, Douglas L., Aaronson, Keith D., Stewart, Garrick C.

Source: In Journal of Cardiac Failure April 2020 26(4):316-323

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF

Authors: DeVore, Adam D., Granger, Bradi B., Fonarow, Gregg C., Al-Khalidi, Hussein R., Albert, Nancy M., Lewis, Eldrin F., Butler, Javed, Piña, Ileana L., Heidenreich, Paul A., Allen, Larry A., Yancy, Cyde W., Cooper, Lauren B., Felker, G. Michael, Kaltenbach, Lisa A., McRae, A. Thomas, Lanfear, David E., Harrison, Robert W., Kociol, Robb D., Disch, Maghee, Ariely, Dan, Miller, Julie M., Granger, Christopher B., Hernandez, Adrian F.

Source: In American Heart Journal February 2020 220:41-50

Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides

Authors: Michaels, Alexander, Aurora, Lindsey, Peterson, Edward, Liu, Bin, Pinto, Yigal M., Sabbah, Hani N., Williams, Keoki, Lanfear, David E. ^*

Source: In Journal of Cardiac Failure January 2020 26(1):52-60